Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Specimen Handling 50Magnetic Resonance Spectroscopy 41Cyclophosphamide 30Vincristine 24Radiation 20Dexamethasone 20Cisplatin 19Biopsy 19Etoposide 18Radiotherapy 17Carboplatin 17Cytarabine 15Doxorubicin 14Leucovorin 13daratumumab 12Methotrexate 12X-Rays 11Platinum 11Gemcitabine 11Docetaxel 11Standard of Care 10Calcium Dobesilate 101,2-diaminocyclohexaneplatinum II citrate 10merphos 9durvalumab 9dexamethasone acetate 9dexamethasone 21-phosphate 9auricularum 9Rituximab 9Radiotherapy, Intensity-Modulated 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hematopoietic Stem Cell Mobilization × 90 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡